by Scott Milner | Jun 24, 2024 | Terlumina | Rx
Exciting News! We are thrilled to announce that KatanaRx is now Terlumina | Rx! This name change marks a new chapter in our commitment to excellence in pharmacy solutions. The Terlumina | Rx solution not only addresses critical areas such as sterile compounding,...
by Scott Milner | May 16, 2024 | Compliance, Diverson, Pharmacy, Sterile Compounding, USP
I distinctly remember the stark realization of the opioid epidemic’s reach—the first time a friend succumbed to narcotic misuse, followed by the revelation of a coworker caught in active diversion. These weren’t distant, abstract events; they touched lives...
by Scott Milner | May 2, 2024 | Compliance, Diverson, Pharmacy, Sterile Compounding, USP
After years of revisions and anticipation, the compendial standards outlined in USP General Chapters <795>, <797>, and <800> became applicable as of November 1, 2023. This milestone marked a significant shift in pharmaceutical practices, especially...
by Rich | Apr 2, 2024 | Compliance, Pharmacy, Sterile Compounding, Uncategorized, USP
✔ If you work with complexity (e.g., healthcare) and have not read this book, you should. ✔ If you have not implemented a checklist strategy, you must. “under conditions of complexity, not only are checklists a help, they are required for success. There must always be...
by Rich | Feb 1, 2024 | Pharmacy, Sterile Compounding, USP
The revised USP General Chapter <797> offers compounders pathways for extended beyond-use dates (BUDs) in sterile preparations, with increasing BUDs tied to stricter requirements. Compliance is emphasized as a continuous journey, according to Kevin Hansen, PharmD....
